CMFI 2023: Advancing the fight against multi-resistant pathogens

CMFI 2023 addresses pressing challenges of our time, such as the rise of multi-resistant pathogens and the roles of microbes in causing or preventing major chronic disease.

PSYC’s Psychedelic Spotlight Continues Ascent as a Top-Ranking Multimedia Platform for the Psychedelics Sector | Psychedelic Invest

PSYC Corporation (OTC Pink Market: PSYC), parent company to Spotlight Media Corporation (“SMC” or the “wholly owned subsidiary”), a multimedia leader for all things psychedelics including the

June 7, 2023

Pharmalittle: We’re reading about a Zepbound-Wegovy faceoff, compounders slamming Novo, and more

Greetings from STAT’s London outpost, with reporter Andrew Joseph here filling in for Ed. No particularly exciting flavored coffee to offer you today, but we

December 4, 2024

Few Stick With Ozempic; Pfizer Making Daily GLP-1; Once-Weekly Insulin Turned Down

Only 25% of patients prescribed semaglutide (Ozempic, Wegovy) for weight loss were still on it 2 years later, according to an analysis of U.S. pharmacy

July 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.